Drug Pricing

Commentary

Biden’s Prescription Drug Plan Is Nothing More Than Price Controls

The Biden administration’s “Comprehensive Plan for Addressing High Drug Prices,” released last week, paints a vivid picture of the difficulties patients face affording their medicines. “Americans pay too much for prescription drugs,” the report notes. “Many Americans do not take medications as prescribed because of their cost.” How does the administration intend to …

Commentary

Under Dems’ Drug Pricing Plan, Dozens of New Meds Will Never Be Invented

The Congressional Budget Office just released an analysis of House Democrats’ effort to impose price controls on prescription drugs, H.R. 3 — the Elijah E. Cummings Lower Drug Costs Now Act. The CBO’s chief finding is grim. By drastically limiting pharmaceutical revenue, H.R. 3 would starve scientists of the funding they need …

Commentary

Budget Reconciliation Bill’s Healthcare Provisions Are Disastrous

Last week, House Democrats passed the $3.5 trillion budget resolution that their Senate counterparts approved earlier this month. The resolution is merely a framework, though. Over the coming months, lawmakers will write the actual legislative text of this mammoth spending bill, which could usher in the most radical changes to our healthcare …

Drug Pricing

Watch Wayne Winegarden Discuss Drug Pricing Reform with Scripps National News

Watch Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, discuss his recent study showing how a two-part drug pricing system would ensure prices more accurately reflect how patients value drugs with Scripps National News.  The report aired on 60 television stations in 42 markets across the …

Commentary

The Real Vaccine Skeptics Work at the FDA

Demonstrators in 50 cities across the country took the streets last month to demand a government takeover of America’s health system. The Democrats who control Washington are trying to give those activists what they’re asking for, albeit in piecemeal fashion. In recent weeks, they’ve proposed lowering Medicare’s eligibility age and adding dental, vision and hearing benefits …

Commentary

Let’s Not Repeat Canada’s Healthcare Mistakes

Demonstrators in 50 cities across the country took the streets last month to demand a government takeover of America’s health system. The Democrats who control Washington are trying to give those activists what they’re asking for, albeit in piecemeal fashion. In recent weeks, they’ve proposed lowering Medicare’s eligibility age and adding dental, vision and hearing benefits …

Drug Pricing

Watch PRI, Pioneer Institute Webinar on ICER, health care innovation

The Pioneer Institute and Pacific Research Institute hosted an educational webinar on the importance of protecting treatment access, innovation, and equity as Washington addresses drug pricing reforms on July 19, 2021. Pioneer Institute, PRI, and special guests explored the current policy landscape on treatment value and access and how policy …

Commentary

America’s drug rebate system is broken

Rebates and discounts are generally viewed as important competitive tools that lower prices for consumers, and rightly so. But consumers should beware when discounts create competitive restrictions that reduces their choices and increases their costs. Such is the case when dominant drug manufacturers use rebates to keep lower-priced drugs off …

Blog

To See the Fallacy of H.R. 3 (Lower Drug Costs Now Act) Just Look at the Inflation Data

Railing about sky high drug prices makes good political theater and helps drum up support for the latest attempt to impose drug price controls (H.R. 3 or the Lower Drug Costs Now Act). This accusation also perpetuates misinformation. If implemented, H.R. 3 would endanger patient access to current efficacious medicines …

Commentary

Government Health Insurance: An Offer Businesses Should Refuse

Executives at many large corporations want the government to take on a greater role providing health coverage and controlling costs, according to a new Kaiser Family Foundation survey. That seems to indicate big business is sympathetic to the core of the Democrats’ healthcare agenda, including the idea of a public option …

Commentary

Biden’s Prescription Drug Plan Is Nothing More Than Price Controls

The Biden administration’s “Comprehensive Plan for Addressing High Drug Prices,” released last week, paints a vivid picture of the difficulties patients face affording their medicines. “Americans pay too much for prescription drugs,” the report notes. “Many Americans do not take medications as prescribed because of their cost.” How does the administration intend to …

Commentary

Under Dems’ Drug Pricing Plan, Dozens of New Meds Will Never Be Invented

The Congressional Budget Office just released an analysis of House Democrats’ effort to impose price controls on prescription drugs, H.R. 3 — the Elijah E. Cummings Lower Drug Costs Now Act. The CBO’s chief finding is grim. By drastically limiting pharmaceutical revenue, H.R. 3 would starve scientists of the funding they need …

Commentary

Budget Reconciliation Bill’s Healthcare Provisions Are Disastrous

Last week, House Democrats passed the $3.5 trillion budget resolution that their Senate counterparts approved earlier this month. The resolution is merely a framework, though. Over the coming months, lawmakers will write the actual legislative text of this mammoth spending bill, which could usher in the most radical changes to our healthcare …

Drug Pricing

Watch Wayne Winegarden Discuss Drug Pricing Reform with Scripps National News

Watch Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, discuss his recent study showing how a two-part drug pricing system would ensure prices more accurately reflect how patients value drugs with Scripps National News.  The report aired on 60 television stations in 42 markets across the …

Commentary

The Real Vaccine Skeptics Work at the FDA

Demonstrators in 50 cities across the country took the streets last month to demand a government takeover of America’s health system. The Democrats who control Washington are trying to give those activists what they’re asking for, albeit in piecemeal fashion. In recent weeks, they’ve proposed lowering Medicare’s eligibility age and adding dental, vision and hearing benefits …

Commentary

Let’s Not Repeat Canada’s Healthcare Mistakes

Demonstrators in 50 cities across the country took the streets last month to demand a government takeover of America’s health system. The Democrats who control Washington are trying to give those activists what they’re asking for, albeit in piecemeal fashion. In recent weeks, they’ve proposed lowering Medicare’s eligibility age and adding dental, vision and hearing benefits …

Drug Pricing

Watch PRI, Pioneer Institute Webinar on ICER, health care innovation

The Pioneer Institute and Pacific Research Institute hosted an educational webinar on the importance of protecting treatment access, innovation, and equity as Washington addresses drug pricing reforms on July 19, 2021. Pioneer Institute, PRI, and special guests explored the current policy landscape on treatment value and access and how policy …

Commentary

America’s drug rebate system is broken

Rebates and discounts are generally viewed as important competitive tools that lower prices for consumers, and rightly so. But consumers should beware when discounts create competitive restrictions that reduces their choices and increases their costs. Such is the case when dominant drug manufacturers use rebates to keep lower-priced drugs off …

Blog

To See the Fallacy of H.R. 3 (Lower Drug Costs Now Act) Just Look at the Inflation Data

Railing about sky high drug prices makes good political theater and helps drum up support for the latest attempt to impose drug price controls (H.R. 3 or the Lower Drug Costs Now Act). This accusation also perpetuates misinformation. If implemented, H.R. 3 would endanger patient access to current efficacious medicines …

Commentary

Government Health Insurance: An Offer Businesses Should Refuse

Executives at many large corporations want the government to take on a greater role providing health coverage and controlling costs, according to a new Kaiser Family Foundation survey. That seems to indicate big business is sympathetic to the core of the Democrats’ healthcare agenda, including the idea of a public option …

Scroll to Top